These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 9283989

  • 21. Evaluation of the efficacy and safety of loratadine in perennial allergic rhinitis.
    Bruttmann G, Charpin D, Germouty J, Horak F, Kunkel G, Wittmann G.
    J Allergy Clin Immunol; 1989 Feb; 83(2 Pt 1):411-6. PubMed ID: 2563743
    [Abstract] [Full Text] [Related]

  • 22. Link between patient preferences and treatment outcomes in seasonal allergic rhinitis: an empiric investigation.
    Ricard N, Kind P, Christian S, Jensen M, Stewart J.
    Clin Ther; 1999 Jan; 21(1):268-77. PubMed ID: 10090440
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Comparison of efficacy and safety of cetirizine and ebastine in patients with perennial allergic rhinitis.
    Murris-Espin M, Melac M, Charpentier JC, Didier A.
    Ann Allergy Asthma Immunol; 1998 May; 80(5):399-403. PubMed ID: 9609610
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A randomized, double-blind, parallel-group study, comparing the efficacy and safety of rupatadine (20 and 10 mg), a new PAF and H1 receptor-specific histamine antagonist, to loratadine 10 mg in the treatment of seasonal allergic rhinitis.
    Saint-Martin F, Dumur JP, Pérez I, Izquierdo I, French Rupatadine-Rhinitis Study Group.
    J Investig Allergol Clin Immunol; 2004 May; 14(1):34-40. PubMed ID: 15160440
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
    Day JH, Briscoe M, Widlitz MD.
    J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Controlled clinical study of the efficacy of loratadine in Nigerian patients with allergic rhinitis.
    Nwawolo CC, Olusesi AD.
    Niger Postgrad Med J; 2001 Sep; 8(3):127-32. PubMed ID: 11721215
    [Abstract] [Full Text] [Related]

  • 32. [In seasonal and perennial rhinitis. Superiority to standard H1 blockers].
    MMW Fortschr Med; 2003 May 29; 145(22):51. PubMed ID: 12866281
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ebastine (20 mg and 10 mg) to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis.
    Hampel F, Howland W, Van Bavel J, Ratner P.
    J Investig Allergol Clin Immunol; 2004 May 29; 14(1):56-63. PubMed ID: 15160443
    [Abstract] [Full Text] [Related]

  • 37. A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit - the Vienna Challenge Chamber (VCC).
    Stübner P, Zieglmayer R, Horak F.
    Curr Med Res Opin; 2004 Jun 29; 20(6):891-902. PubMed ID: 15200748
    [Abstract] [Full Text] [Related]

  • 38. Comparison of efficacy, safety, and skin test inhibition of cetirizine and astemizole.
    Berkowitz RB, Dockhorn R, Lockey R, Findlay S, Howland WC, Mitchell DQ, Woehler T.
    Ann Allergy Asthma Immunol; 1996 Apr 29; 76(4):363-8. PubMed ID: 8612120
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Efficacy and safety of ebastine 20 mg compared to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled study.
    Ratner P, Hampel F, Van Bavel J, Howland W.
    Int Arch Allergy Immunol; 2004 Apr 29; 133(4):371-9. PubMed ID: 15031611
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.